FEATURED/ARCHIVES (02/05/24)
×
Healthcare Costs of Dementia Diseases Before, During and After Diagnosis: Longitudinal Analysis of 17 Years of Swedish Register Data · February 2022
Articles
Alzheimer’s and Dementia
×
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis · September 2021
Articles
Journal of Alzheimer’s Disease Reports
×
Effective Interventions for Potentially Modifiable Risk Factors for Late-Onset Dementia: A Costs and Cost-Effectiveness Modelling Study · October 2020
Articles
Lancet Healthy Longevity
×
Assessing the Cost-Effectiveness of a Hypothetical Disease-Modifying Therapy with Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease · October 2022
Articles
Clinical Therapeutics
×
The Value of Supportive Care: A Systematic Review of Cost-Effectiveness of Non-Pharmacological Interventions for Dementia · May 2023
Articles
PLOS ONE
×
Cost-Effectiveness of Exergaming Compared to Regular Day-Care Activities in Dementia: Results of a Randomised Controlled Trial in the Netherlands · October 2021
Articles
Health and Social Care in the Community
×
Cost-Effectiveness of Dementia Training for Caregivers in Caregiver-Patient Dyads: A Randomized Controlled Study · June 2022
Articles
Alzheimer’s and Dementia: Translational Research and Clinical Interventions
×
Economic Costs of Dementia in 11 Countries in Europe: Estimates from Nationally Representative Cohorts of a Panel Study · June 2022
Articles
Lancet Regional Health-Europe
×
Cost-Effectiveness of Pharmacological Therapies for People with Alzheimer’s Disease and Other Dementias: A Systematic Review and Meta-Analysis · April 2022
Articles
Cost Effectiveness and Resource Allocation